Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Recruiting · NCT07225621 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-07-17 | NCT07225621 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alpheus Medical, Inc. | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Albany Medical Center | Albany | United States | 122 |
| Columbia University | New York | United States | 154 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Dent Neurologic Institute | Buffalo | United States | 2 |
| Mayo Clinic | Rochester | United States | 664 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| New York Langone | New York | United States | 1 |
| Northwell Health | Long Island City | United States | 1 |
| Ohio State University | Columbus | United States | 169 |
| Penn State Milton S. Hershey Medical Center | Hershey | United States | 44 |
| University of Rochester | Rochester | United States | 1 |